Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
34.70
-0.35 (-1.00%)
Sep 24, 2026, 3:00 PM CST

SHA:688363 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,6954,1995,3716,0766,3594,948
Revenue Growth
-23.36%-21.82%-11.61%-4.45%28.53%87.93%
Gross Profit
2,4632,8473,8894,4174,8773,829
Operating Income
101.24235.23232.36570.18961.48746.46
Net Income
224292.06174.27592.56970.92782.33
Earnings Per Share
0.470.610.361.232.011.62
EPS Growth
325.10%69.44%-70.73%-38.81%24.07%20.00%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Countries or Regions
318.9402.77366.16420.91361.49579.43
Mainland China
4,8275,2586,6467,5558,5656,465
Hong Kong
-60.2148.954.5235.327.96
Offset
--1,522-1,690-1,955-2,603-2,125
Total
3,6934,1995,3716,0756,3594,947

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,1801,028749.291,3092,1372,654
Total Debt
482.21341.38359.69208.1389.79300.01
Net Cash (Debt)
697.54686.9389.61,1011,7472,354
Net Cash Growth
28.48%76.31%-64.60%-37.00%-25.77%12.67%
Net Cash Per Share
1.461.430.802.283.624.87

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
933.29627.45564.51699.65635.191,276
Capital Expenditures
-348.01-325.68-721.39-1,030-696.41-784.21
Free Cash Flow
585.28301.77-156.88-330.68-61.22491.85
Free Cash Flow Growth
468.13%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.67%67.80%72.41%72.69%76.69%77.40%
Operating Margin
2.74%5.60%4.33%9.38%15.12%15.09%
Pretax Margin
6.11%7.95%3.97%11.55%17.87%17.99%
Profit Margin
6.06%6.96%3.25%9.75%15.27%15.81%
FCF Margin
15.84%7.19%-2.92%-5.44%-0.96%9.94%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1900.1900.1100.3800.6100.490
Dividend Per Share Growth
72.73%72.73%-71.05%-37.70%24.49%19.51%
Dividend Yield
0.55%0.44%0.22%0.57%0.46%0.32%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
73.9771.54140.1054.4167.0395.28
Forward PE
42.7238.6134.8829.5651.5090.88
P/FCF Ratio
28.3669.24---151.56
PS Ratio
4.494.984.555.3110.2315.07